Biologic therapies: what and when?
T cell activation: for full activation, T cells require interaction between the antigen‐specific T cell receptor and the antigenic peptide presented in the context of self major histocompatibility complex (MHC) by the antigen‐presenting cell. A “costimulatory” second signal is then required, delivered by the interaction between cluster of differentiation (CD)28 on the T cell with CD80/86 on the antigen‐presenting cell. Later, the T cell expresses CTLA4, which has higher affinity for CD80/86, and delivers a down‐regulatory signal, thereby “switching off” the immune response when the pathogen is cleared. Fusion proteins based on the CTLA4 structure have been developed to block the costimulatory pathway, for use in autoimmunity and transplant rejection (fig 4).
Publication
Biologic therapies: what and when?. (2007) Sarah L Johnston. J Clin Pathol. 2007 Jan;60(1):8-17. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | cll | CL1 | ncbigene_synonym | DCLK1 | 9201 |
| Homo sapiens | Primates | cll | CL1 | ncbigene_synonym | ADGRL1 | 22859 |
| Homo sapiens | Primates | cll | CLI | ncbigene_synonym | CLU | 1191 |
| Homo sapiens | Primates | cll | C11 | ncbigene_synonym | AKR1C4 | 1109 |
| Homo sapiens | Primates | cll | C11 | ncbigene_synonym | GZMB | 3002 |
| Homo sapiens | Primates | cll | C11 | ncbigene_synonym | POLR3K | 51728 |
| Homo sapiens | Primates | CD4 | CD4 | ncbigene_symbol | CD4 | 920 |
| Homo sapiens | Primates | CTLA4 | CTLA4 | ncbigene_symbol | CTLA4 | 1493 |
| Homo sapiens | Primates | CD28 | CD28 | ncbigene_symbol | CD28 | 940 |
| Homo sapiens | Primates | MHC | MHC | ncbigene_synonym | HLA-C | 3107 |
| Homo sapiens | Primates | CD80 | CD80 | ncbigene_symbol | CD80 | 941 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|